News

Hemoglobin function is becoming increasingly important across modern therapeutic development – from conventional pharmaceuticals and gene therapy to artificial blood and advanced ICU oxygen treatments. Yet oxygen dissociation curve (ODC) …

There is something irreplaceable about a face-to-face conversation with the people shaping a field. Over the past weeks, we have had the privilege of talking to some of the brightest …

What an incredible week at the 26th Meeting of the European Red Cell Society (ERCS) in L’Isle-sur-la-Sorgue, France. We were honored to present OxyDial’s latest work to a full room …

This week, we are honored to participate in the 26th Meeting of the European Red Cell Society (ERCS) in L’Isle-sur-la-Sorgue, France. It is truly inspiring to be part of such …

Accurate measurement of oxygen partial pressure (PO2) is foundational to constructing reliable oxygen dissociation curves. Traditional approaches rely on gas calibration, electrodes, and controlled gas environments. OxyDial takes a different …

In oxygen-affinity testing, differentiation is not only about measuring P50. It is about how confidently you can trust the curve, how quickly you can validate sample integrity, and how easily …

For years, measuring hemoglobin function and the oxygen dissociation curve (ODC) has been a technically demanding process. Traditional approaches such as Hemox analyzers or tonometry require large sample volumes, complex …

OxyDial has successfully closed its Seed Round – an important milestone that strengthens our ability to scale both technology and impact. This investment enables us to continue manufacturing our unique …

At OxyDial, progress is driven by people. Inventors, engineers, business leaders, and operators work together as one team, each playing a distinct role. In our Meet the Team series, we …